Display Settings:

Format

Send to:

Choose Destination

    Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.

    Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.

    Lehmann F, Haile S, Axen E, Medina C, Uppenberg J, Svensson S, Lundbäck T, Rondahl L, Barf T.

    Department of Medicinal Chemistry, Biovitrum AB, SE-751 37 Uppsala, Sweden.

    Low micromolar human A-FABP inhibitors were found by utilizing a fluorescence polarization assay, X-ray crystallography and modeling. The carbazole- and indole-based inhibitors displayed approximately 10-fold preferences over human H-FABP and E-FABP, and are highly selective against I-FABP. This communication describes the SAR for drug-like synthetic inhibitors of human A-FABP.

    PMID: 15357969 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Structures reported by this article